NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
194 hedge funds and large institutions have $4.37B invested in NEVRO CORP. in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 72 reducing their positions, and 46 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 207 → 194 (-13)
13% less call options, than puts
Call options by funds: $32.9M | Put options by funds: $37.7M
15% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 72
24% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 46
31% less capital invested
Capital invested by funds: $6.36B → $4.37B (-$1.99B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$127M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$57.1M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$48.8M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$39.6M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$39.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$165M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$125M |
| 3 |
PA
Perceptive Advisors
New York
|
-$73.1M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$52.6M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$41.4M |
NVRO Hedge Fund Activity: Q3 2021 in Review
194 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2021, worth a combined $4.37B — down 31% from $6.36B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of NVRO and 35 opened new positions — a net loss of 11 holders — while 72 trimmed existing stakes and 61 added.
The largest buyer was Jackson Square Partners, adding an estimated $127M. The largest seller was Fred Alger Management, cutting an estimated $165M.
- 194 institutional investors held NEVRO CORP. (NVRO) as of Q3 2021, down from 207 in Q2 2021.
- Funds reported $4.37B of NEVRO CORP. stock for Q3 2021, down 31% quarter-over-quarter.
- 35 funds opened new NEVRO CORP. positions in Q3 2021 and 46 closed out, a net change of -11 holders.
- The largest NEVRO CORP. buyer in Q3 2021 was Jackson Square Partners, an estimated $127M added.
- The largest NEVRO CORP. seller in Q3 2021 was Fred Alger Management, an estimated $165M sold.
Based on aggregated 13F filings for Q3 2021.